SCHEMBL9762923

SCHEMBL9762923

CCCCS(=O)(=O)Nc1ccc(CCOCCCCCCNCc2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.52
HPGD P15428 2/20 0.45
ALDH1A1 P00352 1/20 0.45
SIGMAR1 Q99720 4/20 0.44
LMNA P02545 1/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
MAOA P21397 1/20 0.42
S1PR1 P21453 3/20 0.41
S1PR3 Q99500 3/20 0.41
S1PR2 O95136 2/20 0.41
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
ADRB3 P13945 2/20 0.41
CHRM2 P08172 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA7 P43166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10488186 0.96 AR (0.52) ARHPGDALDH1A1SIGMAR1LMNA
SCHEMBL10477677 0.96 AR (0.52) ARHPGDALDH1A1SIGMAR1LMNA
SCHEMBL9763021 0.86 AR (0.51) ARHPGDALDH1A1SIGMAR1LMNA
SCHEMBL9763725 0.86 DRD2 (0.51) ARHPGDALDH1A1SIGMAR1LMNA
SCHEMBL9762652 0.79 POLB (0.51) ALDH1A1CNR1CNR2S1PR1S1PR3
SCHEMBL10477755 0.79 SIGMAR1 (0.69) SIGMAR1MAOACHRM2BCHE
SCHEMBL9764394 0.79 SIGMAR1 (0.69) SIGMAR1MAOACHRM2BCHE
SCHEMBL9762627 0.79 SIGMAR1 (0.52) ARHPGDSIGMAR1CNR1CNR2
SCHEMBL9763280 0.78 SIGMAR1 (0.55) ARALDH1A1SIGMAR1MAOAADRB1
Benzene SCHEMBL27952372 0.78 MAOA (0.65) HPGDALDH1A1SIGMAR1LMNACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990505-A Treating asthma, bronchitis; adrenergic stimulants GLAXO GROUP LIMITED (GB) 1991-02-05 US disclosed